ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona

Jewish General Hospital at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

Jewish General Hospital takes part in 4 sessions at ESMO 2026 in Madrid. Its work spans cancer treatment and access to care. It examines breast tumour responses during treatment with trastuzumab deruxtecan and other medicines, and access to early cancer drugs for women in Quebec.

OrganizationESMO 2026 Attendance
Jewish General Hospital
Montreal, Canada
Cancer centre & hospital
Teaching hospital of McGill University in Montreal, Canada, with a cancer centre.
Poster
Fri Oct 23
13:00–15:00
Plasma proteomics reveals a Th17/myeloid signature in ICI-induced colitis: A MIRAE pilot study
ePoster session 22
Biomarkers & precision oncology
Poster
Sun Oct 25
12:00–12:45
Assessing equity in early oncology drug access for women’s cancers across Quebec’s health system
Sunday Poster Display session 6
Gynaecological cancersBreast cancer

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Jewish General Hospital

Tell us what you sell and we’ll find the people at Jewish General Hospital most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction